One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial
Natsuaki, Masahiro, Morimoto, Takeshi, Yamamoto, Erika, Shiomi, Hiroki, Furukawa, Yutaka, Abe, Mitsuru, Nakao, Koichi, Ishikawa, Tetsuya, Kawai, Kazuya, Yunoki, Kei, Shimizu, Shogo, Akao, Masaharu, MiLanguage:
english
Journal:
Cardiovascular Intervention and Therapeutics
DOI:
10.1007/s12928-015-0366-9
Date:
October, 2015
File:
PDF, 1.71 MB
english, 2015